XM76F9ICD-11 MMS 2026-01
Conjugated estrogenic substances
Index terms
- Conjugated estrogenic substances
Sibling codes
XM0SU9– Steroid antineoplastic, hormone estrogenXM0W29– Antineoplastic combination estrogenXM0ZZ0– Progestogens and estrogens, sequential preparationsXM1B43– NormethandroneXM1K26– PregnandiolXM1P34– EpiestriolXM1SH1– NoretynodrelXM26R0– Ovarian stimulantXM2GR3– Estrogen with progesteroneXM39W0– Estradiol benzoateXM3AK8– MestranolXM3HH8– QuinestrolXM3MJ7– Ovarian hormoneXM49U4– DimestrolXM4DR7– DelalutinXM4NZ9– HydroxyestroneXM5A00– Hydroxyprogesterone caproateXM5RK3– DimethisteroneXM6133– EstropipateXM6CL2– Anhydrohydroxy-progesteroneXM70N0– EstrogensXM7JV9– Gonadal tissue extract femaleXM8AV0– OxendoloneXM8FT3– ProgestogenXM8WE5– HexestrolXM9HA7– ProgestogensXM9HS1– QuinestradolXM9N33– Progestogens and estrogens, fixed combinations
Foundation entity
Conjugated estrogenic substances – http://id.who.int/icd/entity/1377110319
Part of: XM3KY1: Agents affecting genitourinary system, sex or anabolic hormones › XM6S30: Medicaments › X: Extension Codes